We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current ARMP market cap is 70.56M. The company's latest EPS is USD and P/E is N/A.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.23M | 1.53M | 966k | 0 | 2.97M |
| Operating Income | -10.34M | -9.58M | -10.23M | -11.91M | -9.76M |
| Net Income | -31.16M | -19.85M | -25.02M | 8.99M | -5.48M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 823k | 4.47M | 5.51M | 4.53M |
| Operating Income | -19.09M | -21.59M | -23.82M | -36.95M | -40.89M |
| Net Income | -19.48M | -22.18M | -23.16M | -36.92M | -69.05M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 112.76M | 98.36M | 120.36M | 108.31M | 98.24M |
| Total Liabilities | 125.15M | 130.43M | 176.87M | 154.41M | 149.21M |
| Total Equity | -12.39M | -32.07M | -56.51M | -46.1M | -50.97M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 25.45M | 39.52M | 69.77M | 95.83M | 98.36M |
| Total Liabilities | 10.86M | 20.66M | 44.37M | 59.75M | 130.43M |
| Total Equity | 14.59M | 18.86M | 25.4M | 36.08M | -32.07M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -39.32M | -47.42M | -10.58M | -20.76M | -29.62M |
| Investing | -5.74M | -8.13M | -250k | -1.62M | -1.96M |
| Financing | 54.03M | 53.99M | 34.93M | 35.02M | 34.96M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -15.58M | -18.27M | -23.58M | -32.48M | -47.42M |
| Investing | 2.88M | -824k | -1.3M | -2.21M | -8.13M |
| Financing | 8.98M | 23.21M | 25.52M | 44.02M | 53.99M |
| Market Cap | 70.56M |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 36.18M |
| Average Volume (1 week) | 8.58k |
| Average Volume (1 Month) | 7.2k |
| 52 Week Change | -45.68% |
| 52 Week High | 4.48 |
| 52 Week Low | 1.80 |
| Spread (Intraday) | 16.16 (95.68%) |
| Company Name | Armata Pharmaceuticals Inc |
| Address |
711 capitol way s ste 204 olympia, washington 98501 1267 |
| Website | https://www.armatapharma.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
